Menu

Topics

Connect

Comments

Want to discuss? Please read our Commenting Policy first.

Quebec City health officials, police issue warning over lethal ‘purple heroin’ mix

Quebec City police and public health officials are warning that a lethal substance known as "purple heroin" has been found in the city. Francis Vachon/The Canadian Press

Quebec City health officials and police are asking the public to be vigilant after a mix of fentanyl and heroin was seized earlier this month.

Story continues below advertisement

The drug is a granular, purple powder that is known as “purp” or “purple,” according to police. It is dangerous and can be lethal.

READ MORE: Dangerous ‘purple heroin’ has made its way to Montreal, police document says

The warning comes following an investigation into the suspicious death of a man on Aug. 2. Quebec City police say they found two packages of drugs next to the victim’s body and that it is the first time they have seized the dangerous substance in the area.

Quebec public health was tipped off about an overdose possibly caused by the same drug, but it was not confirmed, according to police.

In a statement issued on Tuesday, authorities said the drug can lead to overdose and even death among those who consume it.

“Be vigilant,” police said.

READ MORE: 130 police officers deployed in drug-trafficking operation in Quebec

The public health department is also asking people to take preventive measures, including not taking drugs alone and having naloxone on hand in case overdose occurs.

Story continues below advertisement

Authorities say that if an overdose occurs, you should immediately call 911.

Earlier this summer, Montreal police also expressed concerns that the dangerous drug had made its way to the city.

An internal note obtained by the Canadian Press says the police force’s analysis and intelligence department has been informed of the drug’s presence in the greater Montreal area.

WATCH: Preventing more fentanyl deaths

— With files from the Canadian Press

Advertisement
Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article